[{"address1": "22211 West Interstate 10", "address2": "Suite 1206", "city": "San Antonio", "state": "TX", "zip": "78257", "country": "United States", "phone": "210 698 5334", "website": "https://www.bioaffinitytech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Girgenti", "age": 77, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 113750, "exercisedValue": 0, "unexercisedValue": 20135}, {"maxAge": 1, "name": "Ms. Maria  Zannes J.D.", "age": 67, "title": "Founder, President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 299171, "exercisedValue": 0, "unexercisedValue": 20135}, {"maxAge": 1, "name": "Mr. Xavier T. Reveles M.S.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vivienne I. Rebel M.D., Ph.D.", "age": 57, "title": "Executive VP and Chief Medical & Science Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 238390, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Zannes J.D.", "age": 70, "title": "Executive VP, Secretary & General Counsel", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie Anne Overton", "title": "Director of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallas J. Coleman", "title": "Vice President of sales", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Bauta Ph.D.", "title": "Senior Vice President of Therapeutics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.34, "open": 1.51, "dayLow": 1.5999, "dayHigh": 1.5999, "regularMarketPreviousClose": 1.34, "regularMarketOpen": 1.51, "regularMarketDayLow": 1.5999, "regularMarketDayHigh": 1.5999, "beta": 2.941, "volume": 15, "regularMarketVolume": 15, "fiftyTwoWeekLow": 1.5999, "fiftyTwoWeekHigh": 1.5999, "currency": "USD", "profitMargins": -1.1941301, "floatShares": 8662338, "bookValue": 0.299, "priceToBook": 5.3508363, "netIncomeToCommon": -8736142, "SandP52WeekChange": 0.24014747, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BIAFW", "underlyingSymbol": "BIAFW", "shortName": "bioAffinity Technologies, Inc. ", "longName": "bioAffinity Technologies, Inc.", "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "161da299-1f9e-36c5-92e1-35f41187c175", "messageBoardId": "finmb_423045573", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.5999, "recommendationKey": "none", "totalCash": 801311, "totalCashPerShare": 0.06, "ebitda": -8034549, "totalDebt": 1380004, "quickRatio": 1.03, "currentRatio": 1.152, "totalRevenue": 7315883, "debtToEquity": 40.197, "revenuePerShare": 0.744, "returnOnAssets": -0.69784, "returnOnEquity": -1.5151801, "freeCashflow": -4287389, "operatingCashflow": -7027216, "revenueGrowth": 120.474, "grossMargins": 0.35473, "ebitdaMargins": -1.09823, "operatingMargins": -0.87077004, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]